Danaher Corp., US2358511028

Danaher stock trades at EUR 198.48 ahead of October 21 results

Published on 09/30/2026 at 13:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher stock enters the October 21, 2026 earnings date after Goldman Sachs raised its target from USD 210.00 to USD 250.00. Q2 adjusted EPS was USD 1.94.

Schwarz-Weiß-Reportagefoto eines Forschers am Mikroskop in einem klassischen Diagnostiklabor
Danaher Corp. Diagnostik-Labor US2358511028 in dokumentarischer Schwarzweiß-Reportage mit Forscher am alten Mikroskop, Illustration mit AI erstellt.

Danaher Corporation stock (ISIN US2358511028) was trading at EUR 198.48 at Lang & Schwarz on September 30, 2026 at 1:40 p.m. CEST. The next company checkpoint is the third-quarter 2026 earnings call scheduled for October 21, 2026.

October 21 results set the next test

According to Danaher on September 22, 2026, the company will discuss third-quarter financial performance and future expectations during an 8:00 a.m. ET webcast. The event gives investors a defined date for testing whether the recovery visible in the second quarter can continue.

Danaher is listed as NYSE: DHR under ISIN US2358511028, according to Financialdata. The company operates across biotechnology, diagnostics and life sciences, which makes the mix between recurring tools and cyclical demand important for the next update.

Q2 delivered a measurable upgrade

Danaher's Q2 2026 earnings supplement reported adjusted EPS of USD 1.94, up 8.00 percent year over year, and adjusted operating margin of 27.10 percent. Core revenue grew 3.00 percent, or 4.50 percent excluding respiratory revenue, giving the business a clearer comparison between underlying demand and a temporary testing headwind.

The same Danaher document raised full-year adjusted EPS guidance to USD 8.45-8.60 from USD 8.35-8.55. The higher range followed Q2 performance and the contribution from the Masimo acquisition, while the Q3 outlook calls for core revenue growth of 2.00 percent to 3.00 percent.

Goldman target reaches USD 250

Yahoo Finance reported on September 21, 2026 that Goldman Sachs raised its Danaher price target from USD 210.00 to USD 250.00 and maintained a Buy rating. That target is a USD 40.00 increase, while the upcoming earnings release remains the next concrete test for the valuation case.

Danaher had a market capitalization of USD 159.0 billion as of September 29, 2026. Its primary-market 52-week range was USD 160.93 to USD 242.80, placing the latest USD 226.23 finance quote within that band and leaving the October report as the next dated operating catalyst.

Danaher stock awaits the report

Danaher stock was trading at EUR 198.48 at Lang & Schwarz on September 30, 2026 at 1:40 p.m. CEST. The quote is presented without a daily percentage because the same-day Lang & Schwarz page did not provide a valid prior close.

Danaher stock facts

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • Ticker: DHR
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of September 30, 2026, 1:40 p.m. CEST): EUR 198.48
  • Market capitalization: USD 159.0 billion (as of September 29, 2026)
  • Sector / Industry: Healthcare industry
  • Index membership: S&P 500
  • Next earnings date: October 21, 2026

More news and analyses on Danaher stock

Disclaimer...

en | US2358511028 | DANAHER CORP. | boerse | 70204129 | bgmi